Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Hemispherian | Pioneering Epigenetic Cancer |
Description | Targeted cancer therapeutics Explore Hemispherian’s dynamic pipeline of next-generation epigenetic cancer therapies. Learn about our ongoing research, preclinical studies, and clinical trials aimed at revolutionizing cancer treatment and patient |
Keywords | N/A |
WebSite | hemispherian.com |
Host IP | 198.49.23.144 |
Location | United States |
Site | Rank |
US$1,486,443
Last updated: 2023-05-12 02:23:47
hemispherian.com has Semrush global rank of 7,120,559. hemispherian.com has an estimated worth of US$ 1,486,443, based on its estimated Ads revenue. hemispherian.com receives approximately 171,513 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.144. According to SiteAdvisor, hemispherian.com is safe to visit. |
Purchase/Sale Value | US$1,486,443 |
Daily Ads Revenue | US$1,373 |
Monthly Ads Revenue | US$41,164 |
Yearly Ads Revenue | US$493,957 |
Daily Unique Visitors | 11,435 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
hemispherian.com. | A | 300 | IP: 198.49.23.144 |
hemispherian.com. | A | 300 | IP: 198.185.159.144 |
hemispherian.com. | A | 300 | IP: 198.49.23.145 |
hemispherian.com. | A | 300 | IP: 198.185.159.145 |
hemispherian.com. | NS | 21600 | NS Record: ns-cloud-a3.googledomains.com. |
hemispherian.com. | NS | 21600 | NS Record: ns-cloud-a1.googledomains.com. |
hemispherian.com. | NS | 21600 | NS Record: ns-cloud-a2.googledomains.com. |
hemispherian.com. | NS | 21600 | NS Record: ns-cloud-a4.googledomains.com. |
hemispherian.com. | MX | 300 | MX Record: 10 alt4.aspmx.l.google.com. |
hemispherian.com. | MX | 300 | MX Record: 5 alt1.aspmx.l.google.com. |
hemispherian.com. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
hemispherian.com. | MX | 300 | MX Record: 5 alt2.aspmx.l.google.com. |
hemispherian.com. | MX | 300 | MX Record: 10 alt3.aspmx.l.google.com. |
hemispherian.com. | TXT | 300 | TXT Record: google-site-verification=1jZZnKOjO25oalAuuRl3IOwuziQ3Uv5PlbhtYVhXxCo |
hemispherian.com. | TXT | 300 | TXT Record: v=spf1 include:_spf.google.com ~all |
Home News Pipeline Science Team Advisors Board Home News Pipeline Science Indication Scientific Rationale Mechanism of Action Key Publications About Team Advisors Board Targeted cancer therapeutics redefined Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as a targeted therapy for particularly aggressive cancers. The Company’s lead compound is currently in late stage preclinical development for glioblastoma multiforme, a deadly cancer of the central nervous system. First-In-Class targeted therapeutics pipeline Hemispherian’s targeted therapeutics act on an entirely new mechanism of action. These drugs work by restoring a cancer cell’s normal epigenetic complement. The drug-induced restoration of this modified DNA base triggers the DNA damage response and results in cancer cytotoxicity. Treatment with these compounds is highly targeted towards cancers and is well tolerated |
HTTP/1.1 301 Moved Permanently Age: 308013 Date: Sat, 20 Nov 2021 20:15:58 GMT Location: https://hemispherian.com/ Server: Squarespace Set-Cookie: crumb=BeaAUso48JTtNDRmODMzODY3ZGU4Y2QwMmJkOGI2N2EzODhiMGQw;Path=/ X-Contextid: VGzxwai4/YMGmjR7r HTTP/2 200 accept-ranges: bytes age: 382793 content-type: text/html;charset=utf-8 date: Fri, 19 Nov 2021 23:29:38 GMT etag: W/"0bdd48176f8a24a666e185a9a2275a88" expires: Thu, 01 Jan 1970 00:00:00 GMT last-modified: Fri, 19 Nov 2021 23:29:39 GMT server: Squarespace set-cookie: crumb=BTh3BE/Pp4GbZjcwMjBmMzI5MzlmYWMwYTU5NDI2YjI3YTRjMzY5;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: 80WGaOV3/vne6z7Ig content-length: 28751 |
Domain Name: HEMISPHERIAN.COM Registry Domain ID: 1908427121_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2021-02-07T06:37:36Z Creation Date: 2015-03-09T12:44:42Z Registry Expiry Date: 2022-03-09T12:44:42Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-CLOUD-A1.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A2.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A3.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A4.GOOGLEDOMAINS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-24T08:22:06Z <<< |